Reply

Affiliations

¹ Department of Ophthalmology, National University Hospital, Singapore, Republic of Singapore; Department of Ophthalmology, National University of Singapore, Singapore, Republic of Singapore.
² Moorfields Eye Hospital, London, UK.
³ Department of Ophthalmology, St. Thomas' Hospital, London, UK.
⁴ Moorfields Eye Hospital, London, UK; UCL Institute of Ophthalmology, London, UK. Electronic address: keith@keithbarton.co.uk.

Comment

Victor Koh et al. Ophthalmol Glaucoma. 2021 Jan-Feb.

. 2021 Jan-Feb;4(1):e1-e2.

doi: 10.1016/j.ogla.2020.09.018. Epub 2020 Nov 11.

¹ Department of Ophthalmology, National University Hospital, Singapore, Republic of Singapore; Department of Ophthalmology, National University of Singapore, Singapore, Republic of Singapore.
² Moorfields Eye Hospital, London, UK.
³ Department of Ophthalmology, St. Thomas' Hospital, London, UK.
⁴ Moorfields Eye Hospital, London, UK; UCL Institute of Ophthalmology, London, UK. Electronic address: keith@keithbarton.co.uk.

No abstract available

Comment on

Treatment Outcomes Using the PAUL Glaucoma Implant to Control Intraocular Pressure in Eyes with Refractory Glaucoma.
Koh V, Chew P, Triolo G, Lim KS, Barton K; PAUL Glaucoma Implant Study Group. Koh V, et al. Ophthalmol Glaucoma. 2020 Sep-Oct;3(5):350-359. doi: 10.1016/j.ogla.2020.05.001. Epub 2020 May 11. Ophthalmol Glaucoma. 2020. PMID: 32980037 Clinical Trial.
Re: Koh et al.: Treatment outcomes using the PAUL glaucoma implant to control intraocular pressure in eyes with refractory glaucoma (Ophthalmology Glaucoma. 2020;3:350-359).
Marques RE, Teixeira FJ, Barata AD, Pinto LA. Marques RE, et al. Ophthalmol Glaucoma. 2021 Jan-Feb;4(1):e1. doi: 10.1016/j.ogla.2020.09.017. Epub 2020 Oct 29. Ophthalmol Glaucoma. 2021. PMID: 33132097 No abstract available.